Director John Hernandez filed a Form 4 with the SEC on November 20, 2026, disclosing the acquisition of 1,109 restricted stock units of ResMed Inc on November 19, 2026.

Key Highlights

  • Reporting person: John Hernandez, a director of ResMed Inc (NYSE:RMD)
  • Transaction date: November 19, 2026
  • Securities acquired: 1,109 shares of ResMed Common Stock in the form of Restricted Stock Units, acquired at a price of $0
  • Vesting schedule: The RSUs vest in full on the earlier of November 11, 2027, or the annual meeting of stockholders in the year following the grant date
  • Beneficial ownership following transaction: 6,227 shares of ResMed Common Stock held directly

Hernandez RSU Award Details and Ownership Position at ResMed

According to the filing, John Hernandez, a director of ResMed Inc (NYSE:RMD), reported the acquisition of 1,109 shares of ResMed Common Stock via a Restricted Stock Unit award on November 19, 2026. The transaction was recorded with a price of $0, consistent with an RSU grant rather than an open-market purchase. The filing notes that the transaction code is "A," indicating an acquisition.

The filing states that the RSUs "vest in full on the earlier of 11/11/2027, or the annual meeting of stockholders in the year following the grant date." Following this transaction, Hernandez directly holds 6,227 shares of ResMed Common Stock, according to the disclosure. No derivative securities were reported in Table II of the filing.

The Form 4 was signed by John Hernandez in his capacity as Director and filed on November 20, 2026, one day after the date of the earliest transaction. The filing was made by one reporting person and does not indicate that it is an amendment to a previously filed form.

What Was Disclosed

ResMed director John Hernandez disclosed the award of 1,109 Restricted Stock Units of ResMed Common Stock at $0 on November 19, 2026, bringing his direct beneficial ownership to 6,227 shares. The RSUs vest in full no later than November 11, 2027.